Article Information
History
- January 8, 2022.
Article Versions
- Version 1 (February 18, 2021 - 02:15).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Martin Wiegand, PhD1,†,
- Sarah L. Cowan, BM BCh2,
- Claire S. Waddington, Dphil3,
- David J. Halsall, PhD4,
- Victoria L. Keevil, PhD5,6,
- Brian D. M. Tom, PhD1,
- Vince Taylor8,
- Effrossyni Gkrania-Klotsas, PhD9,
- Jacobus Preller, FRCP*,10 and
- Robert J. B. Goudie, PhD*,1
- 1MRC Biostatistics Unit, School of Clinical Medicine, University of Cambridge, UK
- 2Addenbrooke’s Hospital, Cambridge, UK
- 3Department of Medicine, University of Cambridge, UK
- 4Cambridge University Hospitals Trust, Cambridge, UK
- 5Department of Medicine for the Elderly, Addenbrooke’s Hospital, Cambridge, UK
- 6Department of Medicine, University of Cambridge
- 8Cancer Research UK, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
- 9Department of Infectious Diseases, Cambridge University Hospitals, Cambridge, UK
- 10Cambridge University Hospitals, Cambridge, UK
- ↵†Corresponding author: Martin Wiegand, MRC Biostatistics Unit, School of Clinical Medicine, East Forvie Building, University Forvie Site, CB2 0SR, University of Cambridge, UK martin.wiegand{at}mrc-bsu.cam.ac.uk
Posted January 08, 2022.
Development and validation of a dynamic 48-hour in-hospital mortality risk stratification for COVID-19 in a UK teaching hospital: a retrospective cohort study
